Use of Discharge Disposition to Determine Stroke Severity After TAVR.
作者信息
Butala Neel M, Kapadia Samir R, Yeh Robert W, Cohen David J
机构信息
Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, CO (N.M.B.).
Division of Cardiology, University of Colorado School of Medicine, Aurora (N.M.B.).
出版信息
Circ Cardiovasc Interv. 2024 Sep;17(9):e013698. doi: 10.1161/CIRCINTERVENTIONS.123.013698. Epub 2024 Jun 5.
Abstract
摘要
相似文献
1
Use of Discharge Disposition to Determine Stroke Severity After TAVR.利用出院处置情况确定经导管主动脉瓣置换术后的卒中严重程度
Circ Cardiovasc Interv. 2024 Sep;17(9):e013698. doi: 10.1161/CIRCINTERVENTIONS.123.013698. Epub 2024 Jun 5.
2
5-Year Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.低风险患者经导管与外科主动脉瓣置换术的5年超声心动图结果
JACC Cardiovasc Imaging. 2025 Jun;18(6):625-640. doi: 10.1016/j.jcmg.2025.01.015. Epub 2025 Apr 16.
3
Age and sex-related outcomes in cardiovascular magnetic resonance versus computed tomography-guided transcatheter aortic valve replacement: a secondary analysis of a randomized clinical trial.心血管磁共振成像与计算机断层扫描引导下经导管主动脉瓣置换术的年龄和性别相关结局：一项随机临床试验的二次分析
J Cardiovasc Magn Reson. 2025;27(1):101882. doi: 10.1016/j.jocmr.2025.101882. Epub 2025 Mar 13.
4
Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials.女性主动脉瓣置换术：RHEIA和PARTNER 3试验的汇总分析。
JACC Cardiovasc Interv. 2025 Jun 23;18(12):1540-1553. doi: 10.1016/j.jcin.2025.03.036.
5
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.高危手术患者中经导管主动脉瓣自膨胀置换术与外科瓣膜置换术的比较：一项关于超声心动图变化及风险预测的研究
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.115.003426.
6
The Impact of Concomitant Mitral Regurgitation on Echocardiography Parameters After TransCatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术后合并二尖瓣反流对超声心动图参数的影响：一项系统评价和Meta分析
Catheter Cardiovasc Interv. 2025 Jul;106(1):367-376. doi: 10.1002/ccd.31555. Epub 2025 Apr 24.
7
Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.在Evolut低风险试验中使用索赔数据评估结果和治疗效果
Circ Cardiovasc Interv. 2025 Jan;18(1):e014592. doi: 10.1161/CIRCINTERVENTIONS.124.014592. Epub 2025 Jan 21.
8
Mid-Term Outcomes of Balloon-Expandable Aortic Valve-in-Valve Replacement in the United States.美国球囊扩张式主动脉瓣中置瓣膜置换术的中期结果
JACC Cardiovasc Interv. 2025 Aug 25;18(16):1989-2000. doi: 10.1016/j.jcin.2025.06.039.
9
Stroke volume index (SVI) predicts all-cause mortality following transcatheter aortic valve replacement (TAVR).每搏输出量指数（SVI）可预测经导管主动脉瓣置换术（TAVR）后的全因死亡率。
Cardiovasc Revasc Med. 2025 Mar;72:38-43. doi: 10.1016/j.carrev.2024.06.014. Epub 2024 Jun 17.
10
Immediate transcatheter aortic valve replacement versus temporizing balloon aortic valvuloplasty in severe aortic stenosis: A systematic review and meta-analysis immediate TAVR vs. temporizing BAV.严重主动脉瓣狭窄患者中，直接经导管主动脉瓣置换术与临时球囊主动脉瓣成形术的比较：一项系统评价和荟萃分析（直接经导管主动脉瓣置换术 vs. 临时球囊主动脉瓣成形术）
Cardiovasc Revasc Med. 2025 Aug;77:112-121. doi: 10.1016/j.carrev.2025.04.019. Epub 2025 Apr 29.
引用本文的文献
1
Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement.医疗保险优待计划用于低风险主动脉瓣置换术长期结果评估的索赔验证
Circ Cardiovasc Qual Outcomes. 2025 May;18(5):e011991. doi: 10.1161/CIRCOUTCOMES.125.011991. Epub 2025 Mar 29.
2
Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.在Evolut低风险试验中使用索赔数据评估结果和治疗效果
Circ Cardiovasc Interv. 2025 Jan;18(1):e014592. doi: 10.1161/CIRCINTERVENTIONS.124.014592. Epub 2025 Jan 21.
3
Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry.经心尖主动脉瓣置换术（TAVR）后使用脑保护装置对致残性卒中的影响：STS/ACC TVT 注册研究的更新结果。
Circ Cardiovasc Interv. 2024 Sep;17(9):e013697. doi: 10.1161/CIRCINTERVENTIONS.123.013697. Epub 2024 Jun 5.
本文引用的文献
1
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.经导管主动脉瓣置换术中的脑栓塞保护。
N Engl J Med. 2022 Oct 6;387(14):1253-1263. doi: 10.1056/NEJMoa2204961. Epub 2022 Sep 17.
2
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术的STS-ACC TVT注册研究
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
3
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study.利用行政索赔评估经导管主动脉瓣置换术随机临床试验的结果和治疗效果：来自 EXTEND 研究的结果。
Circulation. 2020 Jul 21;142(3):203-213. doi: 10.1161/CIRCULATIONAHA.120.046159. Epub 2020 May 21.
4
Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后短期并发症对死亡率和生活质量的影响。
JACC Cardiovasc Interv. 2019 Feb 25;12(4):362-369. doi: 10.1016/j.jcin.2018.11.008.
5
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.经导管主动脉瓣植入术更新的标准化终点定义：瓣膜学术研究联盟-2 共识文件。
J Am Coll Cardiol. 2012 Oct 9;60(15):1438-54. doi: 10.1016/j.jacc.2012.09.001.
Zotero 插件